FINANCIAL CALENDAR FOR SCN

(NGM:SCN)

The Board of Scandinavian Clinical Nutrition i Sverige AB (SCN) has decided on the following financial calendar for the company:

November 30, 2007 Interim Report July-September (Q3, 2007)

February 22, 2008 Year-end Report and Interim Report October-December (Q4, 2007)

May 9, 2008 Interim Report January-March (Q1, 2008)

August 22, 2008 Interim Report April-June (Q2, 2008)

November 7, 2008 Interim Report July-September (Q3, 2008)

For further information:

Ulf Söderberg, CEO, ulf.soderberg@scnutrition.com, +46 708 13 22 81

Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Membraseven, Coldizin, Immulina and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and scientifically documented products, create the right conditions for profitable growth both in Sweden and in the company’s export markets. The SCN share is listed for trade on NGM Nordic MTF since December 6, 2006.